Riddle MC - Search Results

1

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.

Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS, Baron AD. Kendall DM, et al. Among authors: riddle mc. Diabetes Care. 2005 May;28(5):1083-91. doi: 10.2337/diacare.28.5.1083. Diabetes Care. 2005. PMID: 15855571 Clinical Trial.

2

Timely addition of insulin to oral therapy for type 2 diabetes.

Riddle MC. Riddle MC. Diabetes Care. 2002 Feb;25(2):395-6. doi: 10.2337/diacare.25.2.395. Diabetes Care. 2002. PMID: 11815517 Review. No abstract available.

3

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

Riddle MC, Rosenstock J, Gerich J; Insulin Glargine 4002 Study Investigators. Riddle MC, et al. Diabetes Care. 2003 Nov;26(11):3080-6. doi: 10.2337/diacare.26.11.3080. Diabetes Care. 2003. PMID: 14578243 Clinical Trial.

4

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes.

Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-Järvinen H. Janka HU, et al. Among authors: riddle mc. Diabetes Care. 2005 Feb;28(2):254-9. doi: 10.2337/diacare.28.2.254. Diabetes Care. 2005. PMID: 15677775 Clinical Trial.

5

Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1.

Riddle MC, Drucker DJ. Riddle MC, et al. Diabetes Care. 2006 Feb;29(2):435-49. doi: 10.2337/diacare.29.02.06.dc05-1267. Diabetes Care. 2006. PMID: 16443905 Review. No abstract available.

6

Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin.

Riddle MC, Henry RR, Poon TH, Zhang B, Mac SM, Holcombe JH, Kim DD, Maggs DG. Riddle MC, et al. Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):483-91. doi: 10.1002/dmrr.646. Diabetes Metab Res Rev. 2006. PMID: 16634116 Clinical Trial.

7

Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Gerstein HC, Riddle MC, Kendall DM, Cohen RM, Goland R, Feinglos MN, Kirk JK, Hamilton BP, Ismail-Beigi F, Feeney P; ACCORD Study Group. Gerstein HC, et al. Among authors: riddle mc. Am J Cardiol. 2007 Jun 18;99(12A):34i-43i. doi: 10.1016/j.amjcard.2007.03.004. Epub 2007 Apr 19. Am J Cardiol. 2007. PMID: 17599423 Clinical Trial.

8

Combined therapy with insulin plus oral agents: is there any advantage? An argument in favor.

Riddle MC. Riddle MC. Diabetes Care. 2008 Feb;31 Suppl 2:S125-30. doi: 10.2337/dc08-s231. Diabetes Care. 2008. PMID: 18227472 No abstract available.

9

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.

Riddle MC, Ambrosius WT, Brillon DJ, Buse JB, Byington RP, Cohen RM, Goff DC Jr, Malozowski S, Margolis KL, Probstfield JL, Schnall A, Seaquist ER; Action to Control Cardiovascular Risk in Diabetes Investigators. Riddle MC, et al. Diabetes Care. 2010 May;33(5):983-90. doi: 10.2337/dc09-1278. Diabetes Care. 2010. PMID: 20427682 Free PMC article. Clinical Trial.

10

Glycemic control and cardiovascular mortality.

Riddle MC. Riddle MC. Curr Opin Endocrinol Diabetes Obes. 2011 Apr;18(2):104-9. doi: 10.1097/MED.0b013e3283446b7e. Curr Opin Endocrinol Diabetes Obes. 2011. PMID: 21522000 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

229 results

Search Page